Gingras, Isabelle <br/><br/>
HER2-positive breast cancer is lost in translation: time for patient-centered research.  [electronic resource] 

 -  Nature reviews. Clinical oncology  Nov 2017 
 - 669-681 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1759-4782 
<br/><br/><label>Standard No.: </label>10.1038/nrclinonc.2017.96  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Biomarkers, Tumor--genetics<br/>Breast Neoplasms--drug therapy<br/>Chemotherapy, Adjuvant<br/>Clinical Trials as Topic<br/>Female<br/>Humans<br/>Neoadjuvant Therapy<br/>Precision Medicine--methods<br/>Receptor, ErbB-2--genetics<br/>Signal Transduction<br/>Translational Research, Biomedical<br/>Treatment Outcome